Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
BACKGROUND Applications are invited for a research associate (PDRA) specializing in instrument development to join a joint project between the University of Manchester and Oxford University
-
wastes and permanent storage of CO2 in construction materials, with the goal of contributing towards decarbonising concrete. The primary aim of this research project is to develop and maximise
-
of Manchester’s Manchester Institute of Biotechnology (MIB). Imperagen has developed a platform technology to accelerate enzyme development and support sustainable bio-based products and processes. To support
-
help to develop a distinguished and thriving list in new directions. The successful candidate will have experience in commissioning high-quality academic Social Sciences titles for use by both scholars
-
of hyperspectral X-ray imaging, developing cutting-edge techniques that combine 3D imaging with elemental and structural analysis. You’ll be part of the National Research Facility for lab X-ray CT (NXCT) and
-
/non-clinical partners. Your research strategy will have a strong emphasis on developing ex vivo models to mimic in situ normal breast facilitating compound screening for translational prevention trials
-
to protocol. You will have specific responsibility for developing and managing systems for the assurance of compliance with the requirements of the Medicines and Healthcare products Regulatory Agency (MHRA) in
-
developing sustainable cement formulations. You must have, or be about to complete, a PhD qualification (or equivalent) in a relevant academic field. The primary aim of this research project is to develop and
-
Creative Manchester is one of three University of Manchester Research Platforms. It is a University-wide development for advancing inter-disciplinary research in creativity and creative practices
-
are looking to appoint a motivated and enthusiastic scientist for 2.5 years, beginning tentatively from October 2025, who wishes to develop skills in a friendly but ambitious group focusing on lung cancer